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Abstract 
 
         Mutagenetic effects and ultrastructural changes of antidiabetic Glurenor drug were studied 
in vivo in the highly sensitive micronucleus test. 
         Eight groups of forty male mice used in this study to detect chromosomal abnormalities in 
somatic and germ cells. Three groups orally administrate  therapeutic doses of  Glurenor at (30, 
60, 120) mg/kg daily the fourth group act as control group. Control group and the treated group 
with 120 mg/kg were used for ultrastructural examination. While the other four groups were 
used for bone marrow micronucleus test which receives successive doses of Glurenor as (0.0 & 
30) mg/kg for 1, 10 &20 days. A cytogenetic examination of treated and untreated mice showed 
a significant increase  of total chromosomal aberrations (P< 0.01) in both somatic and germ 
cells at dose 120 mg/kg. when compared by control group. Also Glurenor induced micronucleus 
polychromatic erythrocytes. Glurenor revealed ultrastructural changes in liver cells represented 
by deep condensation in the nucleus which revealed by the appearance of a large gap around the 
nucleus. The condensed chromatin appeared as  large sharply marginated electron dense  mass 
that  a  butted  on  the  nuclear  envelope.  In  addition  to  electron  dark  distanced  elsewhere 
(prenuclear), swollen endoplasmic reticulum, Also, observed enlarged nucleolus, and thickening 
the  nuclear  membrane.  Large  vacuoles  "hydropic  degeneration"  also  was  noticed  in  the 
cytoplasm.  
         Our  studies  had  the  objective  of  examining  experimentally  whether  the  supposed 
mutagenic effect of Glurenor can be demonstrated   and verified by methods of mutagenicity 
testing using expermintal mammals. 
                  In conclusion, this study revealed that Glurenor gave a positive reaction with a clear 
dose response in mice. Glurenor gave a mutagenic response from of the chromosomal aberration 
in  somatic  and  germ  cells  as  well  as  in  micronucleus  test.  Glurenor  showed  ultrastructural 
changes in the liver cells of mice.    
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Introduction 
 
 Glurenor  is  one  of  sulphonylureas  (to 
lbutamide,  chlorpropamide,  libenclam-ide, 
glipizide,  gliclazide,  glimepiride)  that 
stimulate pancreatic insulin release. 
         Sulfonylureas  stimulate  insulin 
secretion  from  pancreatic  cells  and  are 
widely  used  in  the  treatment  of  type  2 
diabetes (Ashcroft, and  Ashcroft 1992). 
          They commonly used in the reduction 
of  blood  sugar  levels.  Sulfonylureas  work 
by  stimulating  insulin  production, 
sensitizing  insulin  receptors,  and  inhibiting 
the production of glucose by the liver. 
         The sulfonylurea drugs lower plasma 
glucose  concentrations  in  diabetic  patients 
by  stimulating  insulin  secretion  and  by 
potentiating  the  biologic  effect  of  the 
insulin  on  tissues  such  as  skeletal  muscle, 
fat  and  liver.  The  mechanism  of  the  latter 
so-called  extra-pancreatic  effect  may  be 
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activated  by  increasing  the  deficient 
numbers of insulin receptors on muscle, fat 
or  liver  cells  (Skillman  and  Feldman, 
1981).  Also,  sulfonylurea  drugs  showed 
that  glypentide  induces  a  significant 
decrease  in  total  lipid  and  cholesterol 
values (Lopez et al., 1976). Side effect with 
sulfonylurea  therapy  are  rare  and  include 
dermatological  hypersensitivity,  gastroin-
testinal  discomfort,  and  vasomotor 
symptoms  (most  frequently  reported  with 
chlorpropamide)  (Lebovitz,  1990).  On  the 
other  hand  Ferner  (1988)  suggest  that 
chlorpropamide  is  the  most  toxic  sulfon-
ylurea  but  glyburide  causes  dangerous 
hypoglycemia  as  often  as  chlorpropamide. 
While  the  sulfonylureas,  troglitazone  can 
cause  serious  adverse  events,  their 
incidences  are  low  and  can  be  minimized 
by  strict  adherence  to  the  prescribing 
guidelines  and  close  monitoring  of  treated 
patients  Charles  and  Clark  (1998).  Also, 
sulphonylureas showed cytogenetic changes 
(Abd EL-Azeim et al.,2002; Mahrous and 
Kamal 1995). 
         This study presents the results of an in 
vivo  cytogenetic  investigation  of  Glurenor 
drug in order to evaluate any increase in the 
number  of  chromosome  aberrations  or 
micronucleus polychromatic erythrocytes or 
any change in liver cell produced compared 
with controls as an indication of mutagenic 
activity. 
 
Material and Methods 
drug used 
         Glurenor  (gliquidone  30  mg  tablets, 
manufactured  by  MINAPHARM  Egypt 
under  licence  of  A.MENARINI  Italy)  the 
active ingredient  is gliquidone.  Glurenor  is 
an oral drug of sulfonylurea class. 
Animal and Treatments   
         Forty  male  adult  Swiss  albino  mice 
aged  (10-12)  week  old  and  weight  20-
25gm. were used and divided into 8 groups 
each of five mice.  Animals were obtained 
from a closed random bred colony at animal 
house  of  National  Research  Centre,  Doki, 
Giza,  Egypt.  The  animal  room  was 
maintained  on  a  12  h  light/dark  cycle,  the 
temperature range was 20 to 24°C, and the 
humidity range was 60 to 70%. Mice were 
fed  standard  breeding  granulated  diet,  and 
water was supplied ad libitum.  
         The  animals  were  orally  given  the 
tested  drug  at  specified  doses  calculated 
according to Paget and Barnes 1964. and 
classified into:-  
Micronucleus assays groups 
1.  control group 
2.  single dose of Glurenor (30 mg/kg). 
3.  10 successive doses of Glurenor. 
4.  20 successive doses of Glurenor. 
Chromosomal analysis groups 
1.  control group 
2.  therapeutic dose (30 mg/kg). 
3.  two fold of therapeutic (60 mg/kg). 
4.  four  fold  of  therapeutic  (120 
mg/kg). 
Experimental  design  for  chromosomal 
abnormalities and micronucleus test:  
         After  24  hours  from  the  last 
administration  the  animal  injected 
inraperitonealy (i.p.)  with 0.5 ml of  0.05% 
of colchicines 2 hours. before sacrifice. The 
femora  and  testis  were  removed  from 
animals  and  the    micronucleus,  chromoso-
mes were prepared as follows.        
         For  micronucleus  analysis,  slides 
were prepared according to Salamone et al. 
(1980). The bone marrow cells were mixed 
with  one  drop  of  fetal  calf  serum  and 
smeared  on  clean  glass  slides.  Slides  were 
allowed to air dry before methanol fixation 
at  room  temperature  for  10  min.  Slides 
were stored at .20 .C° in a sealed box. The 
sides    stained  with  5  %  Giemsa  and 
mounted with DPX. Two thousands PCEs/ 
animal were recorded.  
Chromosomal analysis 
         After  one  week  of  treatment  the 
animals  were  injected  intraperitoneal  (i.p.) 
with  colchicines  0.5  ml  of  0.05  %  mg/kg. 
two hr. before sacrifice to arrest the cells of 
bone  marrow  in metaphase. The chromos-
ome  were prepared and slides were stained 
with  Giemsa.  Chromosomal  aberrations 
were  scored  following  the  guide  line  of 
Preston  et  al.  (1987).  The  aberration 
frequencies  per  cell  for  chromatid, 
chromosome  and  mitotic  index  were 
calculated.  The  testis  of  the  same  animals 
were  removed  and  slides  were  prepared 
according  to  RUSSO  (2000).  One  hundred 
metaphase  spreads  per  animal  were Genetic and Ultrastructural studies in bone marrow….. 
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examined in bone marrow and seventy five 
metaphase  spreads  were  examined  in 
spermatocytes. 
 
Statistical Analysis  
         Comparison of reliability analysis (F. 
test)  was  done  statistical  significance 
between the treated and control groups of  
mice  according to Snedecor and Cochran 
(1961) .  
 
Electron microscopy: 
Liver  specimens  of  animals  which  treated 
with  120  mg/kg.  and  control  groups  were 
removed  from  living  animals  to  avoid  the 
shock  reaction.  Specimens  were 
immediately  fixed  by  immersion  in  4  % 
gluteraldehyde in 0.1 M sodium cacodylate 
buffer,  PH  7.3  for  6  hours  (Gupta  and 
Berridge,  1966).  Then  post  fixation  was 
carried out in 1 % osmium tetroxide in the 
same cacodylate buffer for 2 hours (Palde, 
1952).  Specimens  following  dehydration 
were embedded  in pure  resin (1:3  araldite: 
epoxy). Ultrathin sections were mounted on 
copper grids and stained with uranyl acetate 
(Stempex and Ward, 1964) and lead citrate 
(Reynolds,  1963).  Stained  sections  were 
investigated  under  JEOL  100  S 
Transmission  Electron  Microscope  of  Ain 
Shams  University,  at  80  KV  accelerating 
voltage.    
 
Results 
         In the screening test, adult male mice 
were given a dose of Glurenor that corresp-
onded  to  4  times  the  therapeutic  dose.  In 
this  way  chromosomal  aberrations  in 
somatic and germ cells showed Glurenor to 
be positive in both tests (TableS 2&3 ). To 
verify  these  results,  different  doses  of 
Glurenor  was  administered,  and  dose-
response relationships determined.  
Cytogenetic Results 
 
Effect on polychromatic erythrocytes (PCE) 
         Table  (1)  shows  the  induction 
micronucleated  polychromatic  erythrocytes 
(Mn PCEs) in bone marrow cells of animals 
treated  with  Glurenor.  The  results  indicate 
that  there  was  non-significant  difference 
between  the  control  and  treated  animals 
with  single  dose  (30  mg/kg)of  Glurenor. 
Repeated  treatment  (oral  administration) 
with  drug  for  10  &20  consecutive  days 
showed significant increase in Mn PCEs as 
P<0.05 & 0.01 respectively. Fig (1) shows 
polychromatic  erythrocytes  with 
micronuclei (arrow). 
 
 
 
Fig.(1):  Photograph  showing  micronuclei  
in  polychromatic  erythrocytes
   
Table (1): the mean value of micronuclei detected in polychromatic erythrocytes of bone 
marrow cells induced by Glurenor in male mice 
 
Doses  Number of examined 
cells 
Number of animal  M ±S.E 
0.0 mg/kg  10000  5  2.4 ± 0.67 
30 mg/kg  10000  5  3.2 ± 0.74 
300 mg/kg  10000  5  5.8 ± 0.66 * 
600 mg/kg  10000  5  6.8 ± 0.66** 
*   P< 0.05    ** P< 0.01 
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E.E   = end to end associations  
C.F   = centric fusions 
C.V   = centromeric attenuations  
Endo = endomitosis 
 
Effect  of  Glurenor  on  bone  marrow 
cells 
         The present  study indicated  that  oral 
administration    of     different    doses     of  
Glurenor  to  male  mice  induced  structural 
and  numerical  chromosomal  abnormalities. 
Structural  chromosomal  aberrations  were 
noticed  as  gaps;  breaks;  deletions; 
fragments;  ring;  end  to  end  associations; 
centric fusion; endomitosis and centromeric 
attenuations.  While,  numerical  changes 
were noticed as polyploidy.  
         Table (2) represented the mean values 
of  different  structural  aberrations  and 
polyploidy  induced  by  Glurenor  in  bone 
marrow cells of male mice. 
         Results showed that Glurenor oral  
administration  caused  statistically  signif-
icant   increase    in   the   frequency of total  
 
structural  chromosomal  aberrations  at  all 
experimental doses (3.2  0.58, 4.6  0.67 
& 6.4  0.51) when compared with control 
(1.2  0.20). this increase was found to be 
statistically significant at (P  0.05, 0.05 & 
0.01)  respectively  even  after  exclusion  of 
gaps.  
         In moderate doses, fragments were the 
most  frequent  type  of  abnormality 
observed,  it  was  increased  significantly  as 
(P  0.05)  compared  with  control.  In  high 
doses  treated  groups  a  significant  increase 
in  breaks  &  deletions  were  noticed  as  P< 
0.05  &  0.01  respectively  compared  with 
control groups Fig.2, 3 . 
chromosomal  abnormalities  detected  in 
spermatocytes  in  the  form  of    chains 
(Fig.5),  autosomal  univalent,  X-Y 
univalents  (Fig  4),  aneuploid  and 
Fig.2
 
Fig3
 
Table (2): Mean value of different chromosomal aberrations induced by Glurenor in male mice 
 
                       
Doses  break  delation  fragment  Ring  E.E  C.F  C. A  Endo  Total  gap  Polyploidy 
  M ± SE  M ± SE  M ± SE  M ± SE  M ± SE  M ± SE  M ± SE  M ± SE  M ± SE  M ± SE  M ± SE 
0.0 mg/kg  0.0± 0.0  0.2 ± 0.20  0.0 ± 0.0  0.0 ± 0.0  0.0 ± 0.0  0.0 ± 0.0  0.6 ± 0.24  0.6 ± 0.40  1.2 ± 0.20  0.4 ± 0.24  0.4 ± 0.24 
30 mg/kg  0.4 ± 0.24  0.8 ± 0.37  0.6 ± 0.24  0.2 ± 0.20  0.0 ± 0.0  0.0 ± 0.0  0.6 ± 0.24  0.6 ± 0.24  3.2 ± 0.58*  0.8 ± 0.37  0.6 ± 0.24 
60 mg/kg  0.6 ± 0.24  1.2 ± 0.37  0.8 ± 0.20*  0.4 ± 0.24  0.2 ± 0.20  0.2 ± 0.20  0.8 ± 0.20  0.6 ± 0.24  4.6 ± 0.67*  0.8 ± 0.37  0.8 ± 0.20 
120 mg/kg  1.2 ± 0.37*  1.4 ± 0.24**  1.2 ± 0.20**  0.6 ± 0.40  0.4 ± 0.24  0.2 ± 0.20  1. ± 0.32  0.6 ± 0.40  6.4 ± 0.51**  1.2 ± 0.37  1.2 ± 0.58 Genetic and Ultrastructural studies in bone marrow….. 
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polyploidy (Fig 5)  there were a  significant 
increase as (P 0.05, 0.05 & 0.01) respecti-
vely    in  total  structural  abnormalities  in 
spermatocyte  cells  with  different  doses  of 
the  drug.  There  was  a  significant  increase 
as (P 0.05) in  the frequency of the ploidy 
in  speermatocyte  cells  with  low  doses 
treated  animals  and  highly  significant 
increase  of  ploidy    with  other  doses  as 
(P<0.001) as compared with control. while 
anuploidy  showed  increase  but  non-
significant in all treated groups.  
 
 
 
 
Fig. 4 
 
Fig. 5 
 
Table (3): Mean values of different aberrations induced by Glurenor drug in spematocyte 
of mice 
Doses  X-Y  Auto  Chain  Total  Ploidy  N-1 
   M ± SE   M ± SE   M ± SE   M ± SE   M ± SE   M ± SE  
0.0 mg/kg 
0.2 ± 
0.20  0.2 ± 0.20  0.0 ± 0.0  0.4 ± 0.24  0.2 ± 0.20  0.4 ± 0.24 
30 mg/kg 
1.4 ± 
0.51*  1.0 ± 0.45  0.4 ± 0.24  2.8 ± 0.97*  1.8 ± 0.37*  1.2 ± 0.37 
60 mg/kg 
2.0 ± 
0.32*  1.4 ± 0.51* 0.6 ± 0.24  4.0 ± 0.84*  2.8 ± 0.37** 1.4 ± 0.51 
120 mg/kg  
3.4 ± 
0.51**  2.6 ± 0.51* 1.6 ± 0.51* 7.6 ± 0.40** 3.4 ± 0.51** 2.2 ± 0.37** 
Auto = autosomal univalents                                 *     p<0.05 
X-Y = x-y univalents                                             **   p<0.01   
 
 
Ultrastructure examination: 
         Ultrastructurally examination  of  liver 
tissue  showed  irregularly  dilated  rough, 
swollen  &  degranulated  endoplasmic 
reticulum  in  the  hepatocytes  of  treated 
groups  (Fig.7).  Nuclei  of  most  of  the 
affected  cells  appeared  swollen  with 
irregularly  shaped  envelop  and  uneven 
distribution of chromatin material and often 
with  peripherally  distributed  heterochro-
matin Also, hypertrophied nucleolus. Large 
vacules  "hydropic  degeneration"  were 
common  in  the  cytoplasm    (Fig.8).  The 
cytoplasm  of  hepatocytes  appeared  devoid 
of glycogen in comparison with control.   
 Sekena, H. Abd El-Aziem & Aziza, M. Hassan 
 
  67  
 
 
Fig. 6: E.M. photomicrograph of hepatocyte of control groups  showing nucleus with its nuclear 
membrane and chromatin rough endoplasmic reticulum and mitochondria. X. 12000 
 
 
Fig. 7: E.M. photomicrograph of hepatocyte of treated group (120 mg/kg) that was revealed by 
appearance of large gap around the nucleus. The condensate chromatin showed large 
sharply marginated electron dense mass that a butted on the nuclear envelope (arrow). 
Presence  of  areas  of  cytoplasmic  lysis.  Electron  dark  inclusions  present  else  where 
(prenuclear). X. 12000   
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Fig.  8:  E.M.  photomicrograph  of  hepatocyte  of  treated  group  (120  mg/kg)    hypertrophied 
nucleolus  with  thickening  nucleular  membrane  and  large  vacuoles  (V)  "hydropic 
degeneration". X. 10000 
 
Discussion 
         Sulfonylurea  drugs  used  on  a  large 
scale  for  the  treatment  of  type  2  diabetes. 
The  present  study  was  conducted  on  one 
drug of this group called Glurenor to detect 
its  mutagenic  side  effect.  The  results 
showed  that  the  drug  produced  abnor-
malities in chromosomal aberrations in both 
somatic  cells  and  germ  cells  of  mice.  In 
additions  the  drug  induce  micronuclei  in 
polychromatic  erythrocytes  cells  in  bone 
marrow,  Similar  observations  were 
recorded  by  Kulkarni  et  al.  (1985)  who 
decided  that  there  was  a  statistically 
significant  increase  in  the  individual 
numbers of sister chromatid exchanges per 
metaphase  in  each  of  the  patients  treated 
with  chlorpropamide  of  the  pooled  control 
values. Also, Abd EL-Azeim et al. (2002) 
which  found  that  oral  treatment  of  either 
Amaryl  or    Diaben  (sulfonylurea  drugs) 
induce chromosomal aberrations in somatic 
and  germ  cells  of  mice..  Similar 
observations  were  recorded  by  Endo  and 
Ingalls  (1968)  who  found  that  diabetes 
drugs (Alloxan and Streptozotocin) induced 
chromosomal  anomalies  such  as  gaps, 
breaks,  polyploidy  and  aneuploidy  in 
tissues  from  defective  fetuses  of  diabetic 
mothers of mice. Similar observations were 
reported  also  by  Koller  (1973).  The 
obtained  results  were  found  to  be  in 
agreement  with  the  study  of  Watson  et  al 
(1976)  cultured  lymphocytes  of  diabetics 
treated  with  chlorpropamide  drug.  In 
addition, Cole and Trasler (1980) recorded 
that insulin  induced a  significant  reduction 
in neuroectoderm mitotic index of mice and 
cell  proliferation.  Also,  Brown  and  Wu 
(1977)  showed  that  chlorpropamide 
(sulfonylurea  drugs)  induced  sister  chrom-
atid  exchanges  in  Chinese  hamster  cells. 
Chlorpropamide  and  tolbutamide  induced 
chromosomal  aberrations  either  in  mice  or 
Chinese  hamster  (Renner  and  Munzner 
1980). Sulfonylurea agents have teratogenic 
effects in animal as reported by Mahrous & 
Kamal  (1995)  in  this  study  on  the 
metformin  and  tolbutamid  (antidiabetic 
drugs) have genotoxic effect in the pregnant 
rats and their fetuses. Also, El Nahas et al. 
(1988)  reported  that  both  alloxan  and 
streptozotocin diabetic drugs induced a high 
frequency  of  severe  scoliosis  in 
combination  with  intrauterine  growth 
retardation  and  skeletal  abnormalities  in 
fetus  and  these  diabetic  drugs  induced 
significant  chromosomal  aberrations  in 
bone marrow of pregnant mice. The authors 
suggested  that  both  drugs  interfere  with 
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These  suggestions  support  our  findings 
about  the    side  effects  of  Glurenor  on 
chromosomes in somatic and germ cells. 
On  the  other  hand  Baster  et  al.  (1982) 
reported  that  chlorpropamide,  did  not 
induce  structural  chromosomal  aberrations 
under  in  vivo  conditions  in  human 
lymphocytes.  While,  Djelic  (2001)  noticed 
that  insulin  stimulates  mitotic  division  and 
has  not  exhibited  genotoxic  properties 
under  experimental  conditions  when 
studied  sister  chromated  exchange  and 
micronuclei  cultured  human  lymphocytes 
treated with insulin. 
         The  present  results  suggested  that 
sulfonylurea agent act directly on DNA as 
there  appear  to  be  no  likely  mechanisms 
where it could react with or damage a DNA 
molecule directly since it binds strongly to 
serum  protein,  it  may  produce  its  effects 
indirectly by affecting enzyme function. 
Few  previous  work  had  been  done  on  the 
ultrastructural  pattern  of  liver  following 
treated sulfonylurea drugs.  
         In this study ultrastructural examina-
tion  of  liver  treated  sulfonylurea  drugs 
showed  different  alterations  were  signify-
cantly more intensified. Areas of cytoplasm 
were  observed  to  be  deprived  of  normal 
cellular  organelles,  The  present  study 
showed  swollen  degranulated  endoplasmic 
reticulum,  Free  ribosomes  were  seen  in 
abundance.  Similar  results  observed  by 
Reaven  et  al.  (1973)  when  studied  the 
effect  of  induced  diabetes  mellitus  and 
insulin  therapy  replacement  on  hepatic 
ultrastructure and protein synthesis in rats. 
He found that increase in hepatocyte Golgi 
very  low  density  lipoprotein  (VLDL) 
content,  but  only  a  small  increase  in 
estimates of VLDL-TG secretion rate (post-
Triton  WR  1339  increment  in  plasma  TG 
level).  Although  these  findings  are 
consistent  with  the  thesis  that  VLDL-TG 
synthesis  and  secretion  are  increased  24  h 
after administration of Streptozotocin. 
         The present results revealed nuclei of 
most of the affected cells appeared swollen 
with  irregularly  thick  nuclear  envelop  and 
uneven  distribution  of  chromatin  material 
and  often  with  peripherally  distributed 
heterochromatin  Also,  enlarged  nucleolus. 
While  Nepomnyashchikh  et  al.  (2001) 
showed  that  degenerative  changes  in  liver 
biopsy  specimens  from  diabetic  patients 
with  diabetes  included  alteration  of 
hepatocyte  nuclei,  and  formation  of 
crescent nuclei..  
         Our  results  revealed  many  large 
vacuoles  "hydropic  degeneration"  in  the 
cytoplasm. Similar observation was noticed 
by Dai et al. (2001) when study the effect 
of  carbon  tetrachloride  in  liver  of  rats.  A 
minimal amount of glycogen was observed 
in hepatocytes  in  comparison  with  control. 
Similar  results  revealed  by  Neupert  et  al. 
(2003)  in  hepatocytes  of  precision-cut  rat 
liver  slices  after  incubation  for  24  and  48 
hours. they observed an organelle-free layer 
of  fine  granular  material  in  the  apical 
cytoplasm  followed  by  parallel  oriented 
stacks of rough endoplasmic reticulum near 
by.  The  cytoplasm  of  parenchymal  cells 
consisted  of  defined  areas  of  clear 
cytoplasmic  material  containing  numerous 
branching  tubular  profiles  of  smooth 
endoplasmic  reticulum,  presumably  in  the 
regions  with  depleted  glycogen  aggregates. 
Dilated  endoplasmic  reticulum  free  of 
ribosomes  and  clumping  of  chromatin  in 
the nucleus of hepatocytes.  
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 تيصخو مبظع عبخً يف قيقذلا ىولخلا بيكرتلا و يثارولا ريغتلا تسارد
ربقع ريثأت تحت ىارئفلا   روٌيرولج  
يسح ذوحه ةزيزع و نيظعلا ذبع ييًبسح تٌيكس  
( ةيلخلا ايجٌلٌيب مسق -   خٌحبلل َمٌقلا ضكشملا )  
 
 شركسل ةضفخملا شيقاقؼلا خذحأ نم ذحاٌب ةجلاؼملا شيذأج ةساسد دحبلا ازى لًانحي   ذكلا
شيغصلا ضيبلأا سأفلا َلػ غفجشملا .  
 َكل  ايميكسقج مكج ةكغلابلا ااكضيبلا باشكنفلا سٌككر نكم شككر نيؼبسأ َلػ دحبلا ٍشجأ ذقل
  ذكمل اكيب هٌمكسملا ةكػشجلاب سٌكنيسٌلج ساقؼب ثػشج اينم غبسأ ،تاػٌمجم بامذ ( 1  ،
10  ، 20  ) ذحج ً  اكفحكت لإكلرً ةةباكض ةػٌمجمك ةؼباشلا ةػٌمجملا تزخأً امٌي  ذكي
 اظؼلا عاخن َف تاٌجف َلػ ةيٌححملا ايلاخلا ةبسن .  
 اكيلاخ َكف ةيمٌكسٌمًشرلا تافلاحخلاا ذيذححل ٍشخلأا تاػٌمجم غبسلأا ثمذخحسأ ذقً
َلاكنلاك سٌكنيسٌلجب اينم خلاذ غيشجج مج ديح ةيصخلاً  اظؼلا عاخن ( 30  ، 00  ، 120  )
 مجم / مجمك ةؼباشلا تزخأً عٌبسأ   ذمل لإلرً مسجلا بصً نم مجك ةةباض ةػٌ .  
 بيكشحلا َف تاشيغحلا ةساسذل ةيذسجلا ايلاخلل لرممك ذبرلا نم تانيػ تزخأ ذق ً
  ةػشجلا   اذخحسا  ذنػ  ايلاخلا  هزيل  قيقذلا 120   مجم /  ةػٌمجملاب  ايحنساقم  ً  مجك
ةةباضلا .  
 ةبككسن نككم ذككيضي ديحساككض َككذاسً شيذأككج وككل سٌككنيسٌلج ااًد بأ ةككساسذلا تشككيرأ ذككقل
ٌسٌمًشرلا تلالاحخلأا  بأً تاٌكجفلا ةبسن اضيأً ةيصخلاً  اظؼلا عاخن ايلاخ َف ةيم
  داكيص  اظؼلا عاخن ايلاخ َف تشير ذقف ةيلاؼلا ةػشجلا َف هٌضٌب شيظج  دايضلا هزى
 اكمأ ةلاةحكستا ً ةكينيجامًشرلا سٌكسرلا نكم لكك َكف ةكلماؼملل ةكجيحن ةيياكصحا ةللاد تار
حكخأ نم لك اييف تشير ذقف ةيصخلا ايلاخل ةبسنلاب   ٌكسمًشرلا لاكصفنأ ً ةلكسلسلا للا
تامٌسٌمًشرلا دذػ َف فػاضحلا ً ٍذسجلا ً َسنجلا .  
 وكبً  صلابٌحيكسلا شكير ذكقف ذكبرلا اكيلاخل قيقذكلا بكيكشحلل ةكيٌلخلا  سٌصلا تشيغج ذفلً
 َككف ذككجٌيً ةككخفحنم ةككيمصلابًذنلاا ةربككفلا تشككير ً تاٌككجف ً  شذاككنحم تاككمًصٌبيس
ً ةيميغ  اسجأ اضيأ  صلابٌحيسلا نيجٌريلج تابيبح  .  ةكلحرلا مكجح داص ذكقف هاٌكنلا َف امأ
للححج بأ ثرشًأ اينأك ً ةينيجامًشرلا .  
 َككذاسً شيذأككج نككم وككل اككمل سٌككنيسٌلج ساككقػ  اذخحككس  نككم  ذككحلاب ةككساسذلا هزككى َككصٌج ً
ساض ٌٍلخً .  
 
 
 